PerioWave Re-Treatment Protocol Compared to Scaling and Root Planing (SRP) and a Single Treatment With PerioWave
Launched by ONDINE RESEARCH LABORATORIES · Jun 12, 2006
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
The key question is whether scaling and root planing (SRP) followed by one or two doses of photodynamic disinfection using 0.01% MB result in improved outcomes that persist over time in adults with chronic periodontitis when compared with subjects with SRP alone. This study is meant to be pivotal in nature in the evaluation of photodynamic disinfection.
Primary Endpoint
The primary outcome of interest in this study is improvement in or stabilization of clinical attachment level. The clinical attachment level is the distance in mm from the cemento-enamel junction to the base of the sulcus ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. The subject is capable of giving informed consent
- • 2. The subject is willing to sign a consent form
- • 3. The subject is an adult male or female \> 18
- • 4. The subject is diagnosed with chronic periodontitis
- • 5. The subject has \>18 fully erupted teeth
- • 6. The subject has at least 4 measurement sites with pocket depth of 6-9 mm in at least two quadrants of the mouth.
- • 7. Subject is willing and able to return for treatment and evaluation procedures scheduled throughout the course of this clinical study
- Exclusion Criteria:
- • 1. The subject is pregnant or nursing or who plans to become pregnant in the next 4 months
- • 2. The subject has significant liver disease by subject report
- • 3. The subject has an active malignancy of any type by subject report
- • 4. The subject has chronic disease or diminished mental capacity that would mitigate the ability to comply with the protocol
- • 5. The subject has any significant disease (either acute or chronic) or who is taking a medication with concomitant oral manifestations that in the opinion of the investigator would interfere with evaluation of safety or efficacy of PERIOWAVE®
- • 6. The subject has an active periapical abscess or periodontal abscess or a history of acute necrotizing ulcerative gingivitis
- • 7. The subject has been treated with antibiotics within the 1-month period prior to beginning the study or any systemic condition which requires antibiotic coverage for routine periodontal procedures (e.g. heart conditions, joint replacements, etc.) by report of the subject
- • 8. The subject has a known allergy to Methylene Blue
- • 9. Has glucose-6-phosphate dehydrogenase (G6PD) deficiency by subject report
- • 10. The subject currently uses anti-coagulant therapy at therapeutic doses
- • 11. The subject is currently using any photosensitizing medications
- • 12. The subject has participated in investigational treatment in the last 30 days or has the expectation for using a separate investigational treatment during the time of the study
About Ondine Research Laboratories
Ondine Research Laboratories is a leading clinical trial sponsor dedicated to advancing innovative therapeutic solutions in the field of healthcare. With a strong emphasis on research and development, the organization specializes in pioneering treatments that address unmet medical needs, utilizing cutting-edge technology and evidence-based methodologies. Committed to rigorous clinical standards and ethical practices, Ondine collaborates with a network of healthcare professionals and institutions to ensure the successful execution of clinical trials, ultimately aiming to enhance patient outcomes and improve quality of life. Their expertise spans multiple therapeutic areas, reflecting a holistic approach to patient care and disease management.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, , China
Wenzhou, , China
Patients applied
Trial Officials
Rong Shu
Principal Investigator
Shanghai Second Medical University
Hu Zhong
Principal Investigator
Wenzhou Hospital Department of Dentistry
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials